Karyopharm Therapeutics reported $8K in Ordinary Share Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Amgen AMGN:US $ 31343M 96M
AstraZeneca AZN:LN 387M 0M
Astrazeneca AZN:US $ 387M 0M
Avrobio Inc AVRO:US $ 4K 0
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 594.1M 0M
Enanta Pharmaceuticals ENTA:US $ 0.21M 0M
Epizyme EPZM:US $ 0.02M 0M
GlaxoSmithKline GSK:LN 1347M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.62M 0M
Mirati Therapeutics MRTX:US $ 0.06M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 890M 11M
Novartis NVS:US $ 890M 11M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Takeda 4502:JP Y 1676277M 14M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Xencor XNCR:US $ 0.6M 0M
YTE INCY:US $ 0.22M 0M